Book a demo
Research & KnowledgeEvent: September 3, 2026

Arex Advisor published a biosimilar development in a nutshell by Erik Hedner

Published

Signal category

Research & Knowledge

Quote

Biosimilar development in a nutshell!Erik Hedner

Staffan Thunell|Arex Advisor team

Company

Arex Advisor

Arex Advisor offers regulatory affairs expertise to the pharmaceutical and biotech industry.

Industry
Pharmaceutical Manufacturing
Location
Stockholm, SE
Company size
40 employees

We are committed to the process of bringing medicines to the market, without detours. Our mission is to help leaders and companies bring their projects to commercialization. We are passionate about the development process, leading to submission and a successful commercialization of important medicines – which ultimately helps to improve the lives of patients. Arex is employee owned. We build our company on partnership – leading to long term relationships and a dedicated team. We are a tight-knit team of experienced specialists who unite in our client-committed view and our strong set of values. We combine our passion for the development process with a strategic mindset for project commercialization. Always working towards new and better ways of helping our clients. Our experts offer a combination of strategic advice and operational expertise throughout your journey from early development to commercialized product. We help you reach your desired destination.

Founded 2020

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.